Drug Interaction Report
2 potential interactions and/or warnings found for the following 2 drugs:
- Brilinta (ticagrelor)
- ceritinib
Interactions between your drugs
ticagrelor ceritinib
Applies to: Brilinta (ticagrelor), ceritinib
Using ticagrelor together with ceritinib is generally not recommended. Combining these medications can significantly increase the blood levels of ticagrelor and increase the risk of serious or life-threatening bleeding complications. Talk to your doctor if you have any questions or concerns. Your doctor may be able to prescribe alternatives that do not interact. Call your doctor promptly if you experience any unusual bleeding or bruising, swelling, vomiting, blood in your urine or stools, headache, dizziness, or weakness during treatment. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food/lifestyle interactions
ceritinib food/lifestyle
Applies to: ceritinib
Do not consume grapefruit or grapefruit juice during treatment with ceritinib unless directed otherwise by your doctor. Grapefruit juice can increase the blood levels of ceritinib to dangerous levels, increasing the risk of an irregular heart rhythm that may be serious. Other, more common side effects such as diarrhea, nausea, vomiting, abdominal pain, and hyperglycemia (high blood sugar) may also increase. You should seek immediate medical attention if you develop sudden dizziness, lightheadedness, fainting, shortness of breath, or heart palpitations during treatment with ceritinib. Food may also increase the blood levels of ceritinib. Therefore, you should take ceritinib on an empty stomach, meaning no food should be eaten for at least two hours before or after taking ceritinib. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Wegovy
Wegovy (semaglutide) an FDA-approved weekly injection for weight loss and to reduce heart risks ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Botox
Botox is used cosmetically to reduce facial lines and wrinkles and for medical purposes for ...
Xarelto
Xarelto (rivaroxaban) is a factor Xa inhibitor used to reduce the risk of blood clots and stroke in ...
Norvasc
Norvasc (amlodipine) is a calcium channel blocker used to treat high blood pressure and angina ...
Caduet
Caduet (amlodipine and atorvastatin) is used to treat high blood pressure or angina in patients ...
Aceon
Aceon (perindopril) is an ACE inhibitor used to treat hypertension (high blood pressure). Includes ...
Katerzia
Katerzia is used for angina, coronary artery disease, high blood pressure
Norliqva
Norliqva is used for angina, coronary artery disease, high blood pressure
Isoxsuprine
Isoxsuprine is used for cerebrovascular insufficiency, coronary artery disease, raynaud's syndrome
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.